G-CSF   Click here for help

GtoPdb Ligand ID: 4934

Synonyms: Granocyte®
Approved drug Immunopharmacology Ligand
G-CSF is an approved drug
Comment: Lenograstim is a recombinant form of glycosylated granulocyte colony-stimulating factor, with exactly the same sequence and function as the endogenous peptide.
Species: Human
No information available.
Summary of Clinical Use Click here for help
There is no information regarding approval of lenograstim on the US FDA website. This drug may be approved by other national approval agencies. This peptide was developed as a immonostimulatory drug to be used to improve the complete remission rate of older patients receiving chemotherapy for acute myeloid leukemia [1].
Treatment with the orally-active CXCR2 antagonist AZD5069 has been shown to shown to markedly increase serum G-CSF concentrations in healthy volunteers (NCT01480739) [2] and to also augment sputum expression of G-CSF in patients with more severe asthma (NCT01890148) [3].
Mechanism Of Action and Pharmacodynamic Effects Click here for help
Granulocyte colony-stimulating factor (G-CSF or GCSF) is a cytokine that stimulates production of granulocytes and stem cells in bone marrow for release into the bloodstream. Despite this being an endogenous ligand we have been unable to find affinity data for this peptide at the G-CSF receptor (CSF3R). Therefore we have not tagged a primary target for this peptide drug.